Rhynexa is a Basel-based biotech venture developing MSC-based cell therapy concepts focused on product quality, reproducibility, and functional characterization to support more consistent and scalable therapeutic development.

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2025
  • Number of employees in Switzerland
    1-9

Key business

Keep browsing

You may also be interested in